Investor Releases

Date Title View
10 July, 2024 ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
01 July, 2024 ICON plc Schedules Second Quarter 2024 Earnings Conference Call
04 June, 2024 ICON plc to Present at the Jefferies Global Healthcare Conference
30 May, 2024 ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
20 May, 2024 ICON plc to hold Investor Day Meeting on May 30, 2024
09 May, 2024 ICON releases its ICON Cares 2023 Report
30 April, 2024 ICON Announces Pricing of USD 2 Billion Notes
24 April, 2024 ICON Reports First Quarter 2024 Results
03 April, 2024 ICON Announces CFO Transition
25 March, 2024 ICON plc Schedules First Quarter 2024 Earnings Conference Call
26 February, 2024 ICON plc to Present at Upcoming Investor Conferences
21 February, 2024 ICON Reports Fourth Quarter and Full Year 2023 Results
30 January, 2024 ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
24 January, 2024 New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
09 January, 2024 ICON Issues Financial Guidance for Full Year 2024
08 January, 2024 Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
04 January, 2024 ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
18 December, 2023 ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
07 December, 2023 ICON Secures Upgraded Credit Rating from Moody’s Investors Service
08 November, 2023 ICON plc to Present at Upcoming Investor Conferences
Displaying 1 - 20 of 394


Search Investor